August 2, 2024: Comprehensive Data Analysis Suggests Rybelsus May Be Associated with an Increased Risk of Blood Clots, DVT, and Pulmonary Embolisms Trial data from an efficacy study point to an increased risk of blood clots for people taking semaglutide drugs, like Rybelsus, for type 2 diabetes
43 The favourable results regarding renal function, combined with the reduction in major cardiovascular events in the CVOTs and the effects on weight loss, may confer GLP-1 RAs a central role in the treatment of CKM syndrome
Even though other GLP-1 medications might not be cheaper, they could receive better coverage
Slow titration, smaller meals, skipping fried and very fatty foods during dose increases, and steady hydration handle most of it
however, to our knowledge, such a dataset is not currently available
Journal reference: Martinelli, S., Mazzotta, A., Longaroni, M., & Petrucciani, N